Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$205.51 - $253.93 $5,548 - $6,856
27 Added 2.29%
1,205 $295,000
Q3 2022

Oct 20, 2022

SELL
$189.27 - $231.83 $43,342 - $53,089
-229 Reduced 16.28%
1,178 $239,000
Q2 2022

Aug 10, 2022

BUY
$194.09 - $276.37 $20,185 - $28,742
104 Added 7.98%
1,407 $280,000
Q1 2022

May 16, 2022

BUY
$245.33 - $277.77 $30,420 - $34,443
124 Added 10.52%
1,303 $348,000
Q4 2021

Jan 31, 2022

BUY
$236.63 - $276.44 $14,907 - $17,415
63 Added 5.65%
1,179 $315,000
Q3 2021

Nov 12, 2021

BUY
$248.9 - $280.09 $8,711 - $9,803
35 Added 3.24%
1,116 $294,000
Q2 2021

Aug 19, 2021

BUY
$242.95 - $267.0 $18,221 - $20,025
75 Added 7.46%
1,081 $280,000
Q1 2021

May 14, 2021

BUY
$221.01 - $248.82 $2,431 - $2,737
11 Added 1.11%
1,006 $245,000
Q4 2020

Feb 05, 2021

BUY
$202.01 - $245.04 $200,999 - $243,814
995 New
995 $244,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.